G.L. Pharma GmbH
ATBRA.061985-000
Firmensitz
Schloßplatz 1
8502 Lannach
Styria
Österreich
Kontakt
Geschäftsführung
Bernhard Frizberg
Member of the Supervisory Board
Seit 5. Januar 2022
Chair of the y Board Alexander Isola
Supervisor
Seit 5. Januar 2022
Deputy Chair of the y Board Eduard Wünscher
Supervisor
Seit 5. Januar 2022
Ilse Bartenstein
Managing Director
Seit 29. Oktober 2007
Johann Bartenstein
Managing Director
Seit 1. Januar 2026
Martin Leopold Bartenstein
Managing Director
Seit 23. Februar 2011
Michael Bartenstein
Managing Director
Seit 1. Januar 2026
Stefan Bartenstein
Member of the Supervisory Board
Seit 6. Februar 2024
Georg StarkEhemalig
Managing Director
27. Oktober 2014 – 2. September 2020
Johann DanklmaierEhemalig
Managing Director
11. Januar 2019 – 9. Juli 2021
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | 310.307.649 € | 48.768.915 € | 384.516.197 € | 87.5% |
| 2023 | 270.859.000 € | 44.346.000 € | 339.094.000 € | 87.9% |
| 2022 | 246.462.667 € | 43.511.247 € | 0 € | 0.0% |
| 2021 | 210.594.687 € | 37.326.713 € | 0 € | 0.0% |
| 2020 | 187.366.500 € | 33.957.496 € | 0 € | 0.0% |
Branche
NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Rohdaten
{
"id": "4ec66150-66d0-4940-9be0-6bb9630d3055",
"euId": "ATBRA.061985-000",
"name": "G.L. Pharma GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "1993-11-19T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Schloßplatz 1",
"city": "Lannach",
"zipCode": "8502",
"state": "Styria",
"country": "AT",
"latitude": 46.945578100000006,
"longitude": 15.332841126928937
},
"contactData": {
"emails": [
"office@gl-pharma.com"
],
"phones": [],
"websites": [
"https://gl-pharma.com/"
],
"faxes": [
"+43 3135700200"
]
},
"managers": [
{
"name": "Bernhard Frizberg",
"position": "Member of the Supervisory Board",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Chair of the y Board Alexander Isola",
"position": "Supervisor",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Deputy Chair of the y Board Eduard Wünscher",
"position": "Supervisor",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Georg Stark",
"position": "Managing Director",
"startDate": "2014-10-27T00:00:00",
"endDate": "2020-09-02T00:00:00"
},
{
"name": "Ilse Bartenstein",
"position": "Managing Director",
"startDate": "2007-10-29T00:00:00",
"endDate": null
},
{
"name": "Johann Bartenstein",
"position": "Managing Director",
"startDate": "2026-01-01T00:00:00",
"endDate": null
},
{
"name": "Johann Danklmaier",
"position": "Managing Director",
"startDate": "2019-01-11T00:00:00",
"endDate": "2021-07-09T00:00:00"
},
{
"name": "Martin Leopold Bartenstein",
"position": "Managing Director",
"startDate": "2011-02-23T00:00:00",
"endDate": null
},
{
"name": "Michael Bartenstein",
"position": "Managing Director",
"startDate": "2026-01-01T00:00:00",
"endDate": null
},
{
"name": "Stefan Bartenstein",
"position": "Member of the Supervisory Board",
"startDate": "2024-02-06T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2019,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 25282300.02,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 173794317.41,
"revenueIsEstimate": false,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 14.547253556257688,
"returnOnSalesIsEstimate": false,
"equity": 181016326.29,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 32288606.45,
"cashIsEstimate": false,
"receivables": 56184067.35,
"receivablesIsEstimate": false,
"liabilities": 230395710.43,
"liabilitiesIsEstimate": false
},
{
"year": 2020,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 33957496.43,
"earningsIsEstimate": false,
"earningsCagr": 34.31331960754098,
"earningsCagrIsEstimate": false,
"revenue": 187366500.01,
"revenueIsEstimate": false,
"revenueCagr": 7.809336232773201,
"revenueCagrIsEstimate": false,
"returnOnSales": 18.123568742644842,
"returnOnSalesIsEstimate": false,
"equity": 206139746.33,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 2123506.55,
"cashIsEstimate": false,
"receivables": 42242664.4,
"receivablesIsEstimate": false,
"liabilities": 22079224.76,
"liabilitiesIsEstimate": false
},
{
"year": 2021,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 37326712.68,
"earningsIsEstimate": false,
"earningsCagr": 21.507079248399343,
"earningsCagrIsEstimate": false,
"revenue": 210594686.61,
"revenueIsEstimate": false,
"revenueCagr": 10.079365779422321,
"revenueCagrIsEstimate": false,
"returnOnSales": 17.72443231159259,
"returnOnSalesIsEstimate": false,
"equity": 232070741.01,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 50416966.98,
"cashIsEstimate": false,
"receivables": 43096684.51,
"receivablesIsEstimate": false,
"liabilities": 15662281.09,
"liabilitiesIsEstimate": false
},
{
"year": 2022,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 43511247.4,
"earningsIsEstimate": false,
"earningsCagr": 19.83811921810572,
"earningsCagrIsEstimate": false,
"revenue": 246462667.16,
"revenueIsEstimate": false,
"revenueCagr": 12.34968453091938,
"revenueCagrIsEstimate": false,
"returnOnSales": 17.65429543605204,
"returnOnSalesIsEstimate": false,
"equity": 263849348.41,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 1850649.03,
"cashIsEstimate": false,
"receivables": 50790221.47,
"receivablesIsEstimate": false,
"liabilities": 106014445.62,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 339094000,
"balanceTotalIsEstimate": false,
"earnings": 44346000,
"earningsIsEstimate": false,
"earningsCagr": 15.082547764353492,
"earningsCagrIsEstimate": false,
"revenue": 270859000,
"revenueIsEstimate": false,
"revenueCagr": 11.73183327640659,
"revenueCagrIsEstimate": false,
"returnOnSales": 16.372356096714526,
"returnOnSalesIsEstimate": false,
"equity": 298020000,
"equityIsEstimate": false,
"equityRatio": 87.88713454086478,
"equityRatioIsEstimate": false,
"cash": 46023000,
"cashIsEstimate": false,
"receivables": 44091000,
"receivablesIsEstimate": false,
"liabilities": 12577000,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 384516196.98,
"balanceTotalIsEstimate": false,
"earnings": 48768915.49,
"earningsIsEstimate": false,
"earningsCagr": 9.471699046209414,
"earningsCagrIsEstimate": false,
"revenue": 310307649.02,
"revenueIsEstimate": false,
"revenueCagr": 13.442329017979437,
"revenueCagrIsEstimate": false,
"returnOnSales": 15.716311100941226,
"returnOnSalesIsEstimate": false,
"equity": 336571433.26,
"equityIsEstimate": false,
"equityRatio": 87.53114586679068,
"equityRatioIsEstimate": false,
"cash": 71818152.67,
"cashIsEstimate": false,
"receivables": 43609242.81,
"receivablesIsEstimate": false,
"liabilities": 15743170.74,
"liabilitiesIsEstimate": false
}
]
}